219 related articles for article (PubMed ID: 10048323)
1. Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.
Zhao Q; Modi S; Smith G; Paine M; McDonagh PD; Wolf CR; Tew D; Lian LY; Roberts GC; Driessen HP
Protein Sci; 1999 Feb; 8(2):298-306. PubMed ID: 10048323
[TBL] [Abstract][Full Text] [Related]
2. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
4. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.
Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM
Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065
[TBL] [Abstract][Full Text] [Related]
5. Flavin reductase P: structure of a dimeric enzyme that reduces flavin.
Tanner JJ; Lei B; Tu SC; Krause KL
Biochemistry; 1996 Oct; 35(42):13531-9. PubMed ID: 8885832
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.
Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990
[TBL] [Abstract][Full Text] [Related]
7. Electrostatic properties deduced from refined structures of NADH-cytochrome b5 reductase and the other flavin-dependent reductases: pyridine nucleotide-binding and interaction with an electron-transfer partner.
Nishida H; Miki K
Proteins; 1996 Sep; 26(1):32-41. PubMed ID: 8880927
[TBL] [Abstract][Full Text] [Related]
8. Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase.
Zhao Q; Smith G; Modi S; Paine M; Wolf RC; Tew D; Lian LY; Primrose WU; Roberts GC; Driessen HP
J Struct Biol; 1996; 116(2):320-5. PubMed ID: 8812989
[TBL] [Abstract][Full Text] [Related]
9. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
10. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.
Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR
Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli.
Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H
Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
13. 1.8 A crystal structure of the major NAD(P)H:FMN oxidoreductase of a bioluminescent bacterium, Vibrio fischeri: overall structure, cofactor and substrate-analog binding, and comparison with related flavoproteins.
Koike H; Sasaki H; Kobori T; Zenno S; Saigo K; Murphy ME; Adman ET; Tanokura M
J Mol Biol; 1998 Jul; 280(2):259-73. PubMed ID: 9654450
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of the sulfite reductase flavodoxin-like domain from Escherichia coli.
Sibille N; Blackledge M; Brutscher B; Covès J; Bersch B
Biochemistry; 2005 Jun; 44(25):9086-95. PubMed ID: 15966732
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI.
Lawson RJ; von Wachenfeldt C; Haq I; Perkins J; Munro AW
Biochemistry; 2004 Oct; 43(39):12390-409. PubMed ID: 15449930
[TBL] [Abstract][Full Text] [Related]
16. Structures of Mycobacterium tuberculosispyridoxine 5'-phosphate oxidase and its complexes with flavin mononucleotide and pyridoxal 5'-phosphate.
Biswal BK; Cherney MM; Wang M; Garen C; James MN
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1492-9. PubMed ID: 16239726
[TBL] [Abstract][Full Text] [Related]
17. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
Cénas N; Lê KH; Terrier M; Lederer F
Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
[TBL] [Abstract][Full Text] [Related]
18. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
19. 1H, 15N and 13C NMR resonance assignment, secondary structure and global fold of the FMN-binding domain of human cytochrome P450 reductase.
Barsukov I; Modi S; Lian LY; Sze KH; Paine MJ; Wolf CR; Roberts GC
J Biomol NMR; 1997 Jul; 10(1):63-75. PubMed ID: 9335117
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of putidaredoxin reductase from Pseudomonas putida, the final structural component of the cytochrome P450cam monooxygenase.
Sevrioukova IF; Li H; Poulos TL
J Mol Biol; 2004 Feb; 336(4):889-902. PubMed ID: 15095867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
